About Pharm-Olam
Pharm-Olam is a company based in Houston (United States) founded in 1994. The company has 177 employees as of April 09, 2024. Pharm-Olam offers products and services including Clinical Development, Regulatory Strategy, and Pharmacovigilance. Pharm-Olam operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Houston, United States
- Employees 177 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharm-Olam International (India) Private Limited
- Date of Incorporation 27 Nov, 2002
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$4.25 M (USD)74.23as on Mar 31, 2023
-
Net Profit
$293.73 K (USD)78.82as on Mar 31, 2023
-
EBITDA
$796.45 K (USD)127.04as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
177
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharm-Olam
Pharm-Olam offers a comprehensive portfolio of products and services, including Clinical Development, Regulatory Strategy, and Pharmacovigilance.
Supports clinical trials and patient recruitment for drug testing
Assists with regulatory submissions and compliance for biotech firms
Monitors drug safety and post-marketing surveillance globally
Funding Insights of Pharm-Olam
Investors in Pharm-Olam
Pharm-Olam has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Quad-C.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are executed by Quad-C in the private equity sector.
|
Locked | Locked | Locked |
Investor details for Pharm-Olam
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharm-Olam
Investment portfolio details for Pharm-Olam
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharm-Olam
Detailed financials for Pharm-Olam
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharm-Olam Comparisons
Peer comparison for Pharm-Olam
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharm-Olam
Pharm-Olam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Pharm-Olam
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharm-Olam
Complete news archive for Pharm-Olam
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharm-Olam
Pharm-Olam was founded in 1994 and raised its 1st funding round 23 years after it was founded.
Pharm-Olam is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
As of Apr 09, 2024, the latest employee count at Pharm-Olam is 177.
Annual revenue of Pharm-Olam is $4.25M as on Mar 31, 2023.
Pharm-Olam is a CRO with 27 offices and has supported clinical trials in 60 countries across all continents. Their full-service offerings such as regulatory, clinical, and project management services are offered across the majority of the 40 countries. In addition, they offer Medical Writing, Data Management, Biostatisticians, Pharmacovigilance, and Medical Monitoring services from North America, Europe, and India. Their services include regulatory issues and the conduct of clinical trials in devices, ranging from diagnostic products, active medical devices, and device delivery systems. They cater to 15 therapeutic areas which include cardiovascular and infectious diseases, oncology and pediatric studies. They also offer rescue studies, orphan drug trial services, and non-interventional clinical trial services.
Pharm-Olam's top competitors include Emmes, Syneos Health and ClinChoice.
Pharm-Olam offers Clinical Development, Regulatory Strategy, and Pharmacovigilance.
Pharm-Olam has 1 investor. Key investors include Quad-C.